280 related articles for article (PubMed ID: 17892155)
41. Determination of a 95 per cent antigenic dose for bovine virus diarrhea vaccine.
Kahrs RF
Am J Vet Res; 1966 Nov; 27(121):1551-4. PubMed ID: 6008309
[No Abstract] [Full Text] [Related]
42. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
[TBL] [Abstract][Full Text] [Related]
43. Influence of the mutant spectrum in viral evolution: focused selection of antigenic variants in a reconstructed viral quasispecies.
Martín V; Domingo E
Mol Biol Evol; 2008 Aug; 25(8):1544-54. PubMed ID: 18436553
[TBL] [Abstract][Full Text] [Related]
44. Viral reproductive strategies: How can lytic viruses be evolutionarily competitive?
Komarova NL
J Theor Biol; 2007 Dec; 249(4):766-84. PubMed ID: 17945261
[TBL] [Abstract][Full Text] [Related]
45. Effects of anesthesia and surgery on serologic responses to vaccination in kittens.
Reese MJ; Patterson EV; Tucker SJ; Dubovi EJ; Davis RD; Crawford PC; Levy JK
J Am Vet Med Assoc; 2008 Jul; 233(1):116-21. PubMed ID: 18593319
[TBL] [Abstract][Full Text] [Related]
46. Human and animal vaccine contaminations.
Pastoret PP
Biologicals; 2010 May; 38(3):332-4. PubMed ID: 20456974
[TBL] [Abstract][Full Text] [Related]
47. Cedivac-FMD can be used according to a marker vaccine principle.
Chénard G; Selman P; Dekker A
Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of lyophilised C-strain vaccine after oral immunisation of domestic pigs and wild boar against classical swine fever: first results.
Faust A; Lange E; Kaden V
Dtsch Tierarztl Wochenschr; 2007 Nov; 114(11):412-7. PubMed ID: 18077931
[TBL] [Abstract][Full Text] [Related]
49. [Changes in the dynamics of viral infectious diseases].
Moennig V
Dtsch Tierarztl Wochenschr; 1992 Jul; 99(7):290-2. PubMed ID: 1516549
[TBL] [Abstract][Full Text] [Related]
50. Assessment of suitability of two serotype A candidate vaccine strains for inclusion in FMD vaccine in India.
Mohapatra JK; Hemadri D; Rao TV; Sreenivasa BP; Subramaniam S; Sanyal A; Periyasamy TR; Singh NK; Pattnaik B; Venkataramanan R
Vet Microbiol; 2008 Sep; 131(1-2):65-72. PubMed ID: 18394827
[TBL] [Abstract][Full Text] [Related]
51. Authorisation within the European Union of vaccines against antigenically variable viruses responsible for major epizootic diseases.
Mackay DK
Rev Sci Tech; 2007 Aug; 26(2):421-8. PubMed ID: 17892162
[TBL] [Abstract][Full Text] [Related]
52. [Basic requirements of viral vaccines and methods for their control].
Osidse DF
Arch Exp Veterinarmed; 1980; 34(1):123-6. PubMed ID: 6774690
[TBL] [Abstract][Full Text] [Related]
53. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
Nijhuis M; van Maarseveen NM; Boucher CA
Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
[TBL] [Abstract][Full Text] [Related]
54. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.
Delrue I; Verzele D; Madder A; Nauwynck HJ
Expert Rev Vaccines; 2012 Jun; 11(6):695-719. PubMed ID: 22873127
[TBL] [Abstract][Full Text] [Related]
55. Transcription of immune genes upon challenge with viral hemorrhagic septicemia virus (VHSV) in DNA vaccinated rainbow trout (Oncorhynchus mykiss).
Cuesta A; Tafalla C
Vaccine; 2009 Jan; 27(2):280-9. PubMed ID: 18977266
[TBL] [Abstract][Full Text] [Related]
56. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
57. Viral vaccines: selected topics.
Kańtoch M
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):367-71. PubMed ID: 9017153
[TBL] [Abstract][Full Text] [Related]
58. Calls for vaccine challenge studies.
Norsworthy GD
J Am Vet Med Assoc; 2004 Apr; 224(7):1069; author reply 1069-70. PubMed ID: 15074846
[No Abstract] [Full Text] [Related]
59. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
[TBL] [Abstract][Full Text] [Related]
60. DNA vaccine protects ornamental koi (Cyprinus carpio koi) against North American spring viremia of carp virus.
Emmenegger EJ; Kurath G
Vaccine; 2008 Nov; 26(50):6415-21. PubMed ID: 18812203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
